ConductScience.org, home

Paper17599507

Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.

Uy KL and 10 others. J Thorac Cardiovasc Surg, 2007. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. Papers, record 17599507. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599507

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
PubMed
Journal
J Thorac Cardiovasc Surg
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
1.81
iCite
Revised in PubMed
2022-04-08
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uy KLKarl L
2Darling GGail
3Xu WWei
4Yi QLQi-Long
5De Perrot MMarc
6Pierre AFAndrew F
7Waddell TKThomas K
8Johnston MRMichael R
9Bezjak AAndrea
10Shepherd FAFrances A
11Keshavjee SShaf

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Cisplatin
Disease-Free Survival
Etoposide
Humans
Lymphatic Metastasis
Male
Middle Aged
Neoplasm Staging
Pneumonectomy
Preoperative Care
Radiotherapy Dosage
Retrospective Studies
Survival Rate

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in18329516Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.https://conductscience.org/library/papers/18329516

Source PubMed

Download CSV of comments and corrections

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42240869Prognostic impact of multiple N2 stations in patients with non small cell lung cancer.Discov Oncol2026https://conductscience.org/library/papers/42240869PubMed
39604439Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer.Sci Rep2024https://conductscience.org/library/papers/39604439PubMed
37980411PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancer.Nat Commun2023https://conductscience.org/library/papers/37980411PubMed
36761426Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers.Front Oncol2022https://conductscience.org/library/papers/36761426PubMed
36313656Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers.Front Oncol2022https://conductscience.org/library/papers/36313656PubMed
35425698Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series.Front Oncol2022https://conductscience.org/library/papers/35425698PubMed
35207557The Potential Role of Nutrition in Lung Cancer Establishment and Progression.Life (Basel)2022https://conductscience.org/library/papers/35207557PubMed
35048154Lung cancer with PET/CT-defined occult nodal metastasis yields favourable prognosis and benefits from adjuvant therapy: a multicentre study.Eur J Nucl Med Mol Imaging2022https://conductscience.org/library/papers/35048154PubMed
33209872Impact of treatment modality on long-term survival of stage IA small-cell lung cancer patients: a cohort study of the U.S. SEER database.Ann Transl Med2020https://conductscience.org/library/papers/33209872PubMed
31179083Novel approach for predicting occult lymph node metastasis in peripheral clinical stage I lung adenocarcinoma.J Thorac Dis2019https://conductscience.org/library/papers/31179083PubMed
30988393Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).Br J Cancer2019https://conductscience.org/library/papers/30988393PubMed
30778734Keys to successful induction chemoradiotherapy followed by surgery for stage III/N2 non-small cell lung cancer.Surg Today2019https://conductscience.org/library/papers/30778734PubMed
28603652Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspiration.J Thorac Dis2017https://conductscience.org/library/papers/28603652PubMed
27442604Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities.Med Sci Monit2016https://conductscience.org/library/papers/27442604PubMed
26319488The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.Ann Thorac Surg2015https://conductscience.org/library/papers/26319488PubMed
25604729Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.Clin Lung Cancer2015https://conductscience.org/library/papers/25604729PubMed
24722151National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer.J Thorac Oncol2014https://conductscience.org/library/papers/24722151PubMed
24163751Surgery in 2013 and beyond.J Thorac Dis2013https://conductscience.org/library/papers/24163751PubMed
23436118Current status and perspective of EBUS-TBNA.Gen Thorac Cardiovasc Surg2013https://conductscience.org/library/papers/23436118PubMed
22853619
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients.
BMC Complement Altern Med2012https://conductscience.org/library/papers/22853619PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17599507

GET https://conductscience.org/api/papers/v1/17599507/cited_by?page=2